The Seattle Hub for Synthetic Biology, a collaboration between Allen Institute, Chan Zuckerberg Initiative, and University of Washington, aims to combine academic creativity with startup-style industrial execution. Its primary goal is to develop a 'recorder mouse' that can track biological actions in real time. Researchers believe this approach, which uses DNA-based technology to record cellular events over time, could lead to significant advancements in medical treatment and drug development. The hub has already demonstrated the potential of this methodology through its 'DNA typewriter' technique, enabling the reconstruction of cell lineage trees and the recording of long-term cellular activity. The applications of this technology range from assessing therapeutic cell actions to revolutionizing immunotherapy. The hub plans to expand its team and facilities, reflecting its commitment to advancing open science and fostering collaboration. With dedicated teams focused on sensor development, DNA recording technology, large DNA molecule engineering, and interpreting DNA sequence readouts, the Seattle Hub for Synthetic Biology is poised to make groundbreaking contributions to the field of life sciences.